Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2024(Status and Outlook)

Global Circulating Tumor Cell (CTC) Diagnostics Market Research Report 2024(Status and Outlook)



Report Overview:

Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation.

The Global Circulating Tumor Cell (CTC) Diagnostics Market Size was estimated at USD 3187.03 million in 2023 and is projected to reach USD 7410.33 million by 2029, exhibiting a CAGR of 15.10% during the forecast period.

This report provides a deep insight into the global Circulating Tumor Cell (CTC) Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Circulating Tumor Cell (CTC) Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Circulating Tumor Cell (CTC) Diagnostics market in any manner.

Global Circulating Tumor Cell (CTC) Diagnostics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

ApoCell, Inc.(US)

Biocep Ltd. (Israel)

Biocept, Inc.(US)

Biofluidica MicrotechnologiesLLc(US)

Celltraffix Inc.(US)

ClearbridgeBiomedics(Singapore)

Creatv Microtech, Inc.(US)

CynvenioBiosystems, Inc.(US)

EpicBiosciencesInc.(US)

FluxionBiosciences, Inc.(US)

Ikonisys, Inc.(US)

IVDiagnostics, Inc.(US)

JanssenDiagnosticsLLc(US)

QIAGEnHannoverGmbH (Germany)

RARECELLsSAs(Italy)

ScreenCell(France)

STEMCELlTechnologies, Inc.(Canada)

Market Segmentation (by Type)

CTC Enrichment

CTC Detection

Market Segmentation (by Application)

Hospitals and clinics

Pharmaceuticals and biotechnology companies

Academic research institutes

CROs

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Circulating Tumor Cell (CTC) Diagnostics Market
  • Overview of the regional outlook of the Circulating Tumor Cell (CTC) Diagnostics Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Circulating Tumor Cell (CTC) Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Circulating Tumor Cell (CTC) Diagnostics
1.2 Key Market Segments
1.2.1 Circulating Tumor Cell (CTC) Diagnostics Segment by Type
1.2.2 Circulating Tumor Cell (CTC) Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Circulating Tumor Cell (CTC) Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Circulating Tumor Cell (CTC) Diagnostics Market Competitive Landscape
3.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Circulating Tumor Cell (CTC) Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Circulating Tumor Cell (CTC) Diagnostics Sales Sites, Area Served, Product Type
3.6 Circulating Tumor Cell (CTC) Diagnostics Market Competitive Situation and Trends
3.6.1 Circulating Tumor Cell (CTC) Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Circulating Tumor Cell (CTC) Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Circulating Tumor Cell (CTC) Diagnostics Industry Chain Analysis
4.1 Circulating Tumor Cell (CTC) Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Circulating Tumor Cell (CTC) Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Circulating Tumor Cell (CTC) Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Circulating Tumor Cell (CTC) Diagnostics Price by Type (2019-2024)
7 Circulating Tumor Cell (CTC) Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Sales by Application (2019-2024)
7.3 Global Circulating Tumor Cell (CTC) Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Circulating Tumor Cell (CTC) Diagnostics Sales Growth Rate by Application (2019-2024)
8 Circulating Tumor Cell (CTC) Diagnostics Market Segmentation by Region
8.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales by Region
8.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales by Region
8.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Circulating Tumor Cell (CTC) Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Circulating Tumor Cell (CTC) Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Circulating Tumor Cell (CTC) Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Circulating Tumor Cell (CTC) Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 ApoCell, Inc.(US)
9.1.1 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.1.2 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.1.4 ApoCell, Inc.(US) Business Overview
9.1.5 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics SWOT Analysis
9.1.6 ApoCell, Inc.(US) Recent Developments
9.2 Biocep Ltd. (Israel)
9.2.1 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.2.2 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.2.4 Biocep Ltd. (Israel) Business Overview
9.2.5 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics SWOT Analysis
9.2.6 Biocep Ltd. (Israel) Recent Developments
9.3 Biocept, Inc.(US)
9.3.1 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.3.2 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.3.4 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics SWOT Analysis
9.3.5 Biocept, Inc.(US) Business Overview
9.3.6 Biocept, Inc.(US) Recent Developments
9.4 Biofluidica MicrotechnologiesLLc(US)
9.4.1 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.4.2 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.4.4 Biofluidica MicrotechnologiesLLc(US) Business Overview
9.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Developments
9.5 Celltraffix Inc.(US)
9.5.1 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.5.2 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.5.4 Celltraffix Inc.(US) Business Overview
9.5.5 Celltraffix Inc.(US) Recent Developments
9.6 ClearbridgeBiomedics(Singapore)
9.6.1 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.6.2 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.6.4 ClearbridgeBiomedics(Singapore) Business Overview
9.6.5 ClearbridgeBiomedics(Singapore) Recent Developments
9.7 Creatv Microtech, Inc.(US)
9.7.1 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.7.2 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.7.4 Creatv Microtech, Inc.(US) Business Overview
9.7.5 Creatv Microtech, Inc.(US) Recent Developments
9.8 CynvenioBiosystems, Inc.(US)
9.8.1 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.8.2 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.8.4 CynvenioBiosystems, Inc.(US) Business Overview
9.8.5 CynvenioBiosystems, Inc.(US) Recent Developments
9.9 EpicBiosciencesInc.(US)
9.9.1 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.9.2 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.9.4 EpicBiosciencesInc.(US) Business Overview
9.9.5 EpicBiosciencesInc.(US) Recent Developments
9.10 FluxionBiosciences, Inc.(US)
9.10.1 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.10.2 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.10.4 FluxionBiosciences, Inc.(US) Business Overview
9.10.5 FluxionBiosciences, Inc.(US) Recent Developments
9.11 Ikonisys, Inc.(US)
9.11.1 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.11.2 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.11.4 Ikonisys, Inc.(US) Business Overview
9.11.5 Ikonisys, Inc.(US) Recent Developments
9.12 IVDiagnostics, Inc.(US)
9.12.1 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.12.2 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.12.4 IVDiagnostics, Inc.(US) Business Overview
9.12.5 IVDiagnostics, Inc.(US) Recent Developments
9.13 JanssenDiagnosticsLLc(US)
9.13.1 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.13.2 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.13.4 JanssenDiagnosticsLLc(US) Business Overview
9.13.5 JanssenDiagnosticsLLc(US) Recent Developments
9.14 QIAGEnHannoverGmbH (Germany)
9.14.1 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.14.2 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.14.4 QIAGEnHannoverGmbH (Germany) Business Overview
9.14.5 QIAGEnHannoverGmbH (Germany) Recent Developments
9.15 RARECELLsSAs(Italy)
9.15.1 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.15.2 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.15.4 RARECELLsSAs(Italy) Business Overview
9.15.5 RARECELLsSAs(Italy) Recent Developments
9.16 ScreenCell(France)
9.16.1 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.16.2 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.16.4 ScreenCell(France) Business Overview
9.16.5 ScreenCell(France) Recent Developments
9.17 STEMCELlTechnologies, Inc.(Canada)
9.17.1 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Basic Information
9.17.2 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product Overview
9.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Product Market Performance
9.17.4 STEMCELlTechnologies, Inc.(Canada) Business Overview
9.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Developments
10 Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Region
10.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast
10.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast by Region
10.2.4 South America Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Circulating Tumor Cell (CTC) Diagnostics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Circulating Tumor Cell (CTC) Diagnostics by Type (2025-2030)
11.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Circulating Tumor Cell (CTC) Diagnostics by Type (2025-2030)
11.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings